首页  期刊介绍 征稿简则 编委会 期刊征订 广告服务 留言板 English

中国应用生理学杂志 ›› 2020, Vol. 36 ›› Issue (3): 250-254.doi: 10.12047/j.cjap.5979.2020.055

• 研究论文 • 上一篇    下一篇

有机磷阻燃剂TDCIPP对雌性大鼠甲状腺的潜在毒性作用

孙景然1, 樊祢祢1, 张桢2, 吴瑾1, 韩殿鹏1, 白家磊1, 杜连群1, 房彦军1△   

  1. 1. 军事医学研究院环境医学与作业医学研究所, 天津 300050;
    2. 中北大学材料科学与工程学院, 山西 太原 030051
  • 收稿日期:2019-11-25 修回日期:2020-04-22 发布日期:2020-09-25
  • 通讯作者: Tel: 022-84655060; E-mail: fangyj86@126.com.+: 并列第一作者
  • 基金资助:
    后勤科研重大项目(AWS18J004,BWS17J025);军事医学创新工程专项课题(17CXZ006)

Potential toxic effects of TDCIPP on the thyroid in female SD rats

SUN Jing-ran1, FAN Mi-mi1, ZHANG Zhen2, WU Jin1, HAN Dian-peng1, BAI Jia-lei1, DU Lian-qun1, FANG Yan-jun1 △   

  1. 1. Institute of Environmental and Operational Medicine, Academy of Military Medical Science, Tianjin 300050;
    2. Materials Science, North University of China, Taiyuan 030051, China
  • Received:2019-11-25 Revised:2020-04-22 Published:2020-09-25

摘要: 目的: 研究磷酸三(1, 3-二氯-2-丙基)酯(TDCIPP)对雌性大鼠甲状腺系统的潜在毒性作用及机制。方法: 将32只离乳3周的雌性SD大鼠随机分为对照组(玉米油灌胃)及TDCIPP低、中、高剂量组(50、100、250 mg/kg·d,溶于玉米油)(n=8),灌胃给药21 d,每天1次。于末次给药后处死动物,取血和甲状腺、肝脏,检测血清中促甲状腺激素(TSH)、三碘甲腺原氨酸(T3), 甲状腺素(T4)和游离甲状腺素(FT4)水平变化;组织切片(HE染色)用于检测甲状腺形态学病变;RT-PCR技术与Western blot技术检测与甲状腺功能相关的基因和蛋白表达的变化。结果: 与对照组比较,TDCIPP染毒后大鼠甲状腺出现滤泡排列不规则、胶质变少、滤泡增生、肥大等现象,TDCIPP低剂量组的血清TSH水平和高剂量组的T3水平均显著升高(P<0.05),低剂量组促甲状腺激素受体(TSHR)mRNA表达和中、高剂量组甲状腺激素受体β(TRβ)蛋白表达均显著降低(P<0.05,P<0.01),中、高剂量组甲状腺过氧化物酶(TPO)mRNA表达显著增高(P<0.05,P<0.01),三个剂量组尿苷二磷酸葡萄糖醛酸转移酶(UGTs)、细胞色素氧化酶-3A1(CYP3A1)蛋白表达水平显著上调(P<0.05)。结论: 大鼠暴露在50 mg/(kg·d)以上剂量的TDCIPP,即可以刺激甲状腺组织的增生,改变血清中甲状腺素的水平,干扰甲状腺的功能,表现出对甲状腺的毒性作用。

关键词: 磷酸三(1,3-二氯-2-丙基)酯(TDCIPP), 大鼠, 毒性作用, 甲状腺, 甲状腺素

Abstract: Objective: To investigate the potential toxic effects and mechanisms of Tris(1; 3-dichloro-2-propyl) phosphate (TDCIPP) on thyroid in female SD rats.Methods: Thirty-two 3-weeks-old female SD rats were randomly divided into normal group(treated with corn oil ), and low/moderate/high-dose group treated with TDCIPP (dissolved in corn oil )(n=8). All rats were treated with corn oil or TDCIPP (50, 100, 250 mg/(kg·d)) once a day during a 21-day period. All rats were sacrificed after the last administration. Serum thyroid stimulating hormone (TSH), 3,3’,5-triiodothyronine (T3), 3,3’,5,5’-tetraiodothyronine (T4), free 3,3’,5,5’-tetraiodothyronine (FT4) were detected with ELISA kit. Morphology of thyroid was observed with hematoxylin and eosin (HE) staining. Expressions of genes and proteins correlate with thyroid were measured respectively by real-time fluorescence quantitative PCR and Western blot. Results: Compared with control group, morphology of thyroid showed follicles irregular arrangement, hypocolloid, and follicular hyperplasia in TDCIPP treatment groups. The levels of serum TSH in low-dose TDCIPP group and T3 in high-dose TDCIPP group were significantly higher than those in control group(P<0.05). Thyroid stimulating hormone receptor (TSHR) mRNA expression was decreased distinctly in low-dose TDCIPP group, while the expression of thyroperoxidase (TPO) mRNA was increased notably in moderate and high-dose TDCIPP groups(P<0.05,P<0.01). Compared with control group, the level of TRβ protein was decreased significantly in moderate and high-dose TDCIPP groups, while the expressions of udp-glucuronosyl-transferases (UGTs) and cytochrome-p450-3A1 (CYP3A1) proteins were upregulated notably in TDCIPP treatment groups(P<0.05). Conclusion: Treated with 50 mg/(kg·d) TDCIPP can cause thyroid hyperplasia, change the levels of thyroid hormones, and disturb thyroid function, therefore, it has toxic effects on the thyroid.

Key words: TDCIPP, mouse, toxic effect, thyroid, thyroid hormone

中图分类号: 

版权所有 © 2015 《中国应用生理学杂志》编辑部
京ICP备16058274号-1
地址:天津市和平区大理道1号,邮编:300050  电话:022-23909086  E-mail:editor@cjap.ac.cn
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:support@magtech.com.cn